Allotar Therapeutics is a drug discovery company developing a therapeutic pipeline targeting a broad range of diseases including intractable ones. Our proprietary AllotarX™ discovery engine combines physics-based simulations and AI to reveal how disease-relevant proteins behave and to identify highly selective intervention sites, enabling a new generation of allosteric drugs. We currently have multiple programs in high-value therapeutic areas—including Alzheimer’s disease, Parkinson’s disease, and ion channel disorders—with potential future expansion into oncology and rare diseases. Our strategy is to advance these programs through key milestones toward strategic pharma partnerships for late-stage development and commercialization. Allotar Therapeutics is expanding the druggable landscape to bring safer, more effective therapies to patients with few or no available treatments.

Allotar Therapeutics

Org chart

Teams

Offices

Allotar Therapeutics

Org chart

Teams

Offices

Related companies